Fernando F Costa Selected Research

hemoglobin Icaria

10/2009

Hb H disease resulting from the association of an α-thalassemia allele [-(α)] with an unstable α-globin variant [Hb Icaria]: First report on the occurrence in Brazil.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fernando F Costa Research Topics

Disease

39	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022 - 02/2002
11	Hemolysis 11/2021 - 05/2003
10	Inflammation (Inflammations) 01/2022 - 09/2012
9	Thalassemia 04/2021 - 09/2002
5	beta-Thalassemia (Cooley's Anemia) 01/2018 - 01/2005
5	Neoplasms (Cancer) 02/2016 - 04/2003
5	Multiple Myeloma 03/2008 - 01/2003
4	Stroke (Strokes) 05/2020 - 07/2014
3	Disease Progression 07/2022 - 11/2007
3	Priapism 05/2020 - 09/2004
3	Acute Chest Syndrome 05/2020 - 09/2004
3	Iron Deficiencies 10/2017 - 10/2006
3	Anemia 01/2017 - 05/2003
2	Macular Degeneration (Age-Related Maculopathy) 11/2021 - 01/2021
2	alpha-Thalassemia 04/2021 - 02/2019
2	Osteonecrosis (Kienbock's Disease) 05/2020 - 04/2015
2	Pain (Aches) 02/2019 - 08/2008
2	Pulmonary Hypertension 06/2015 - 09/2012
2	Hemoglobin SC Disease (Disease, Hemoglobin SC) 06/2015 - 04/2015
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2014 - 07/2009
2	Leukocytosis (Pleocytosis) 06/2012 - 04/2007
2	Myocardial Infarction 10/2008 - 08/2004
2	Adenocarcinoma 07/2007 - 04/2003
2	Colorectal Neoplasms (Colorectal Cancer) 07/2007 - 04/2003
2	Albuminuria 12/2006 - 04/2006
1	Cholelithiasis 04/2021
1	Leg Ulcer 05/2020
1	Venous Thromboembolism 02/2019
1	Congenital Hemolytic Anemia (Hemolytic Anemia, Congenital) 05/2017
1	Liver Failure 01/2017
1	Massive Hepatic Necrosis 01/2017
1	Iron Overload 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Siderosis 01/2016

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2006
9	CytokinesIBA 05/2020 - 01/2005
7	Hemoglobins (Hemoglobin)IBA 11/2021 - 02/2008
7	GlobinsIBA 07/2020 - 03/2002
6	DNA (Deoxyribonucleic Acid)IBA 04/2021 - 02/2002
6	beta-Globins (beta Globin)IBA 01/2018 - 01/2005
6	Hydroxyurea (Hydrea)FDA LinkGeneric 04/2017 - 09/2004
5	EnzymesIBA 01/2018 - 04/2003
4	Fetal Hemoglobin (Hemoglobin F)IBA 04/2021 - 08/2008
4	IronIBA 01/2018 - 10/2006
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2016 - 04/2008
3	Heme (Haem)IBA 11/2021 - 05/2017
3	BilirubinIBA 04/2021 - 05/2003
3	Messenger RNA (mRNA)IBA 01/2016 - 09/2006
3	EndostatinsIBA 06/2015 - 01/2003
3	Codon (Codons)IBA 01/2009 - 02/2006
3	Folic Acid (Vitamin M)FDA LinkGeneric 03/2008 - 10/2006
2	Interleukin-6 (Interleukin 6)IBA 05/2020 - 01/2018
2	NADPH Oxidases (NAD(P)H oxidase)IBA 11/2016 - 01/2008
2	Sickle HemoglobinIBA 10/2016 - 01/2013
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2016 - 09/2008
2	AntigensIBA 01/2016 - 02/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2015 - 04/2011
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2015 - 04/2011
2	Dasatinib (BMS 354825)FDA Link 10/2014 - 01/2014
2	Imatinib Mesylate (Gleevec)FDA Link 10/2014 - 01/2014
2	glucose-6-phosphate dehydrogenase A-IBA 07/2014 - 05/2003
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 07/2011 - 09/2008
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 03/2008 - 07/2007
2	alpha-GlobinsIBA 02/2008 - 01/2007
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 10/2007 - 10/2007
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2007 - 04/2006
2	CreatinineIBA 12/2006 - 04/2006
2	Platelet Membrane GlycoproteinsIBA 10/2004 - 08/2004
2	Glutathione Transferase (Glutathione S-Transferase)IBA 04/2003 - 01/2003
1	Biomarkers (Surrogate Marker)IBA 07/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	Complement System Proteins (Complement)IBA 11/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 05/2020
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2020
1	Serotonin (5 Hydroxytryptamine)IBA 01/2020
1	3,4-dihydroxybenzohydroxamic acidIBA 01/2020
1	Erythropoietin FDA Link 02/2019
1	HemopexinIBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2018
1	PolymersIBA 01/2018
1	AntioxidantsIBA 01/2018
1	Reducing AgentsIBA 01/2018
1	hemoglobin A2'IBA 10/2017
1	hemoglobin BristolIBA 05/2017
1	Chelating AgentsIBA 01/2017
1	Deferasirox FDA Link 01/2017
1	CD40 Ligand (CD40L)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Thrombospondin 1IBA 01/2017
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 11/2016
1	Nitric Oxide DonorsIBA 11/2016
1	3-(1,3-dioxoisoindolin-2-yl)benzyl nitrateIBA 11/2016
1	ruxolitinibIBA 02/2016
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2016
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2016

Therapy/Procedure

9	Therapeutics 02/2019 - 09/2004
1	Ligation 10/2017